Zweig Advisers’s GSK GSK Stock Holding History

Zweig Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-129,600	Closed	-$7.3M	–	31
2016 Q2	$7.3M	Buy	129,600 +72,000	+125%	+$3.79M	1.25%	39
2016 Q1	$2.92M	Hold	57,600	–	–	0.49%	64
2015 Q4	$2.9M	Buy	57,600 +1,600	+3%	+$81.6K	0.48%	64
2015 Q3	$2.69M	Hold	56,000	–	–	0.47%	63
2015 Q2	$2.92M	Hold	56,000	–	–	0.44%	67
2015 Q1	$3.23M	Hold	56,000	–	–	0.46%	63
2014 Q4	$2.99M	Hold	56,000	–	–	0.41%	68
2014 Q3	$3.22M	Sell	56,000 -29,600	-35%	-$1.81M	0.46%	69
2014 Q2	$5.72M	Hold	85,600	–	–	0.8%	63
2014 Q1	$5.72M	Hold	85,600	–	–	0.81%	64
2013 Q4	$5.71M	Buy	+85,600	New	+$5.55M	0.79%	65

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Zweig Advisers's GSK Position: Q3 2016 in Review

Zweig Advisers sold out of GSK (GSK) in Q3 2016, closing a stake of 129,600 shares — an estimated $7.3M sold.

Zweig Advisers first reported a position in GSK in Q4 2013 and held it in 11 quarters. The position peaked at $7.3M in Q2 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Zweig Advisers reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Zweig Advisers sold 129,600 GSK shares in Q3 2016, an estimated $7.3M.
Zweig Advisers first reported a position in GSK in Q4 2013 and held it in 11 quarters.
Zweig Advisers's GSK position peaked at $7.3M in Q2 2016.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Zweig Advisers's 13F filing for Q3 2016.